Long-term preservation of biological samples is essential for reproducible research and future clinical use. Cryopreservation and biobanking support the continuity of regenerative medicine by storing viable cells, tissues, and bioengineered constructs without compromising their functionality. Innovations in cryoprotectants, controlled-rate freezing, and vitrification techniques now allow higher post-thaw survival rates and functionality of stem cells and engineered tissues. These advances are crucial for ensuring the availability of genetically matched materials for transplantation and personalized therapies. Cryopreservation and biobanking also play a central role in multi-center trials and biorepositories, enabling the sharing of standardized, quality-controlled samples. As demand increases for diverse and ethically sourced biospecimens, robust biobanking practices become a cornerstone of translational success in tissue engineering and regenerative medicine.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy